ADAR1 Capital Management, LLC Insider Trades & Stock Holdings

10% Owner · InMed Pharmaceuticals Inc. · Latest filing Oct 15, 2026

ADAR1 Capital Management, LLC, 10% Owner at InMed Pharmaceuticals Inc. has 9 Form 4 trades on file since Oct 1, 2026. Open-market activity: 9 purchases ($84.28K) and 0 sales ($0), net +$84.28K. Latest filing: acquired 984 shares of $INM on Oct 15, 2026 at $1.32.

Trades on file

9

Open-market bought

$84.28K

Open-market sold

$0

Net open-market

+$84.28K

Latest filing

Oct 15, 2026

All insider trades by ADAR1 Capital Management, LLC

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 15, 2026	$INM	Buy (Open-market buy)	984	$1.32	$1.30K						10% Owner		Read
Oct 14, 2026	$INM	Buy (Open-market buy)	8.02K	$1.33	$10.67K						10% Owner		Read
Oct 13, 2026	$INM	Buy (Open-market buy)	564	$1.33	$750.12						10% Owner		Read
Oct 8, 2026	$INM	Buy (Open-market buy)	2.26K	$1.33	$3K			0.0%			10% Owner		—
Oct 7, 2026	$INM	Buy (Open-market buy)	3.05K	$1.33	$4.05K			-1.5%			10% Owner		—
Oct 6, 2026	$INM	Buy (Open-market buy)	5.60K	$1.33	$7.44K			0.0%			10% Owner		—
Oct 5, 2026	$INM	Buy (Open-market buy)	18.18K	$1.33	$24.18K			+2.3%			10% Owner		—
Oct 2, 2026	$INM	Buy (Open-market buy)	8.31K	$1.33	$11.05K			+2.3%			10% Owner		—
Oct 1, 2026	$INM	Buy (Open-market buy)	16.43K	$1.33	$21.85K			-1.5%			10% Owner		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks ADAR1 Capital Management, LLC traded

• $INM

Frequently asked questions

Has ADAR1 Capital Management, LLC been buying or selling stock?

ADAR1 Capital Management, LLC has 9 open-market purchases and 0 open-market sales on file, net +$84.28K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was ADAR1 Capital Management, LLC's latest insider trade?

acquired 984 shares of $INM on Oct 15, 2026 at $1.32.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.